{"id":244883,"date":"2026-02-04T19:33:27","date_gmt":"2026-02-04T19:33:27","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=244883"},"modified":"2026-02-04T19:33:27","modified_gmt":"2026-02-04T19:33:27","slug":"de-la-vedeta-bursei-la-alerta-rosie-pentru-investitori-actiunile-novo-nordisk-se-prabusesc-in-timp-ce-gigantul-farmaceutic-anticipeaza-un-declin-sever-al-vanzarilor-pe-fondul-exploziei-competitiei-i","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=244883","title":{"rendered":"De la vedeta bursei la alert\u0103 ro\u015fie pentru investitori: Ac\u0163iunile Novo Nordisk se pr\u0103bu\u015fesc, \u00een timp ce gigantul farmaceutic anticipeaz\u0103 un declin sever al v\u00e2nz\u0103rilor pe fondul exploziei competi\u0163iei \u00een industria tratamentelor pentru obezitate"},"content":{"rendered":"<p>\nAc\u0163iunile Novo Nordisk au suferit o c\u0103dere abrupt\u0103, de aproape 20%, miercuri, dup\u0103 ce pionierul medicamentelor pentru sl\u0103bit a avertizat c\u0103 v\u00e2nz\u0103rile ar putea sc\u0103dea semnificativ \u00een acest an, pe fondul unei competi\u0163ii tot mai acerbe \u015fi al presiunilor cresc\u00e2nde asupra pre\u0163urilor, informeaz\u0103 Financial Times.<\/p>\n<p>\nTitlurile companiei farmaceutice daneze au pierdut aproximativ 18% \u00een primele ore de tranzac\u0163ionare, reac\u0163ia investitorilor fiind una dur\u0103 dup\u0103 anun\u0163ul f\u0103cut de grup mar\u0163i seara.<\/p>\n<p>\nNovo Nordisk estimeaz\u0103 c\u0103 v\u00e2nz\u0103rile sale ar putea \u00eenregistra un declin de p\u00e2n\u0103 la 13% \u00een 2026, \u00eentr-un context \u00een care pia\u0163a tratamentelor pentru obezitate devine tot mai aglomerat\u0103, iar marjele sunt erodate de competi\u0163ia intens\u0103 \u015fi de negocierile dure privind pre\u0163urile medicamentelor.<\/p>\n<p>\nAvertismentul vine \u00een pofida unor rezultate financiare solide raportate pentru 2025. Compania a anun\u0163at v\u00e2nz\u0103ri nete de 309 miliarde de coroane daneze (aproximativ 48,9 miliarde de dolari), \u00een cre\u015ftere cu 10% fa\u0163\u0103 de anul precedent, la cursuri de schimb constante. Evolu\u0163ia pozitiv\u0103 a fost sus\u0163inut\u0103 \u00een special de performan\u0163a pie\u0163ei din Statele Unite \u015fi de expansiunea opera\u0163iunilor interna\u0163ionale.<\/p>\n<p>\nDe asemenea, v\u00e2nz\u0103rile tratamentelor vedet\u0103 pentru obezitate \u015fi diabet au urcat cu 10%, p\u00e2n\u0103 la 289,5 miliarde de coroane daneze, impulsionate \u00een principal de cererea tot mai mare pentru terapiile destinate \u00eengrijirii obezit\u0103\u0163ii.<\/p>\n<p>\nCu toate acestea, perspectivele sumbre pentru anul \u00een curs arat\u0103 c\u0103 nici m\u0103car liderii globali ai industriei farmaceutice nu sunt imuni la presiunile unei pie\u0163e aflate \u00eentr-o transformare rapid\u0103.<\/p>\n<div>\n&nbsp;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ac\u0163iunile Novo Nordisk au suferit o c\u0103dere abrupt\u0103, de aproape 20%, miercuri, dup\u0103 ce pionierul medicamentelor pentru sl\u0103bit a avertizat c\u0103 v\u00e2nz\u0103rile ar putea sc\u0103dea semnificativ \u00een acest an, pe fondul unei competi\u0163ii tot mai acerbe \u015fi al presiunilor cresc\u00e2nde asupra pre\u0163urilor, informeaz\u0103 Financial Times. Titlurile companiei farmaceutice daneze au pierdut aproximativ 18% \u00een primele [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[7172,16164,16199,15146,7216,301,9426,14884,8789,30016,474,7633,323,161,16559,60,23264,340,19707,12923,7212,7230],"class_list":["post-244883","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-actiuni","tag-alerta","tag-anunt","tag-avertizare","tag-bursa","tag-competitie","tag-declin","tag-explozie","tag-fond","tag-gigant","tag-industrie","tag-investitori","tag-medicamente","tag-miliarde","tag-obezitate","tag-piata","tag-presiuni","tag-preturi","tag-timp","tag-tratament","tag-vanzari","tag-vedete"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/244883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=244883"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/244883\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=244883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=244883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=244883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}